Drug targets for heart failure with preserved ejection fraction: a mechanistic approach and review of contemporary clinical trials

RB Patel, SJ Shah - Annual review of pharmacology and …, 2019 - annualreviews.org
… and clinical findings in patients with heart failure with preserved ejection fraction stratified by
study design: … Effects of candesartan in patients with chronic heart failure and preserved left-…

Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study

H Nougué, T Pezel, F Picard… - … of heart failure, 2019 - Wiley Online Library
… This study aimed at evaluating the effects of sacubitril/valsartan on neprilysin (NEP), and the
metabolism of natriuretic peptides in heart failure (HF) and providing additional mechanistic

Potentiation of insulin signaling contributes to heart failure in type 2 diabetes: a hypothesis supported by both mechanistic studies and clinical trials

M Packer - JACC: Basic to Translational Science, 2018 - jacc.org
… the clinical course of patients with diabetes who have established heart failure. It is therefore
noteworthy that, in several observational studies, patients with chronic heart failure who had …

… mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of …

RA de Boer, JS Hulot, CG Tocchetti… - … of heart failure, 2020 - Wiley Online Library
… pre-clinical and clinical studies. … studies indicate that acquired somatic mutations in
haematopoietic cells are associated with a markedly increased risk of coronary heart disease in …

Transitioning from preclinical to clinical heart failure with preserved ejection fraction: a mechanistic approach

A Bayes-Genis, F Bisbal, J Núñez, E Santas… - Journal of clinical …, 2020 - mdpi.com
… More than one-fourth of the cohort had a KCCQ score below 75, a threshold value that has
been used in clinical trials of established heart failure to denote at least a moderate burden of …

Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase

M Gheorghiade, PS Pang, CM O'Connor, K Prasad… - American heart …, 2011 - Elsevier
… toward greater success in AHFS clinical trials. Acute heart failure syndromes (AHFS) have
been defined as the gradual or rapid onset of signs or symptoms of heart failure (HF) requiring …

A mechanistic role for cardiac myocyte apoptosis in heart failure

D Wencker, M Chandra, K Nguyen… - … clinical investigation, 2003 - Am Soc Clin Investig
… development of cardiac dilation and contractile dysfunction, the hallmarks of heart failure. To
… that myocyte apoptosis may be a causal mechanism of heart failure, and they suggest that …

[HTML][HTML] Omecamtiv mecarbil: a novel mechanistic and therapeutic approach to chronic heart failure management

PH Patel, M Nguyen, R Rodriguez, S Surani, G Udeani - Cureus, 2021 - ncbi.nlm.nih.gov
Chronic heart failure is a syndrome of reduced cardiac output resulting from impaired ventricular
… Several phases 2 and 3 clinical trials conducted with Omecamtiv mecarbil to date are …

Soluble CD146 is a novel marker of systemic congestion in heart failure patients: an experimental mechanistic and transcardiac clinical study

M Arrigo, QA Truong, D Onat, J Szymonifka… - Clinical …, 2017 - academic.oup.com
Heart failure (HF) 9 is one of the leading causes of mortality and is associated … in patients
with chronic heart failure (CHF) and are associated with adverse outcome (3). The congestive

Mechanisms and models in heart failure: a combinatorial approach

DL Mann - Circulation, 1999 - Am Heart Assoc
heart failure in precise mechanistic and/or clinical terms is that the clinical syndrome of heart
failure … 14 Second, clinical studies have shown that antagonizing neurohormones leads to …